Casey Dougan

Casey Dougan is currently serving as the Chief Operating Officer at Ajax Health, specifically for Cordis-X. Prior to this role, Casey was the Chief Operating Officer and Executive Vice President at Kedalion Therapeutics, which was acquired by Novartis. Previously, Casey held various positions at McKinsey & Company, BD, Synexis, Smith & Nephew, Pfizer, and Cubist Pharmaceuticals. Casey holds an MBA in Health Care Management/Finance from The Wharton School and a BA in Biology/Economics from Brown University.